Table 1 Patient characteristics and baseline data at the time of enrollment in Phase 1 clinic.
Variable | N (%)(range) |
|---|---|
Median Age | 54.4 |
Caucasian | 129 (80%) |
African Americans | 32 (20%) |
Male | 76 (47%) |
ECOG 0 | 59 (38%) |
Immunotherapy (IOT) | 40 (25%) |
Targeted treatments (TT) | 122 (75%) |
Base line Albumin | 4 (2.8–4.8) |
Base line LDH | 190.5 (109.0–895.0) |
Prior Rx ≤ 2 | 72 (44%) |
Prior Rx 3–4 | 52 (32%) |
Prior Rx ≥ 5 | 38 (24%) |
Prior Radiation | 72 (45%) |
Hematological malignancies | 55 (34%) |
Non-Hematological Malignancies | 107 (66%) |
